Windlas Biotech Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on July 28, 2025
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech Limited submitted the voting results and scrutinizer's report for its 24th AGM held on July 28, 2025, via video conferencing. A total of 73.12% of outstanding shares (1,53,24,533 votes from 173 shareholders) were polled, and all 9 resolutions were passed with the requisite majority. Key items include adoption of FY25 audited financial statements, declaration of a final dividend of Rs. 5.80 per equity share, re-appointment of Executive Director Pawan Kumar Sharma, and appointment of M/s J C Bhalla & Co. as new statutory auditors in place of M/s S S Kothari Mehta & Co. LLP. Three special resolutions approving the 'Windlas Plan 2025' (an employee stock option/stock-based plan, including grants to subsidiary employees and grants of 1% or more of issued capital) were also passed, with 94.13% votes in favor and 5.87% against.
Shareholders have confirmed a Rs. 5.80 final dividend for FY25, and the company has shifted to a new statutory auditor (J C Bhalla & Co.). The approval of the Windlas Plan 2025 introduces a new employee stock incentive scheme, which may lead to mild equity dilution over time but aligns management and employee interests.